Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

(2013) David Safronetz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Syrian hamster model of hantavirus pulmonary syndrome

(2012) David Safronetz et al.   ANTIVIRAL RESEARCH

Construction and Nonclinical Testing of a Puumala Virus Synthetic M Gene-Based DNA Vaccine

(2012) R. L. Brocato et al.   Clinical and Vaccine Immunology

DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)

(2012) Rebecca Brocato et al.   PLoS One

Vesicular Stomatitis Virus-Based Vaccine Protects Hamsters against Lethal Challenge with Andes Virus

(2011) K. S. Brown et al.   JOURNAL OF VIROLOGY

In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection

(2011) David Safronetz et al.   PLoS One

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus

(2011) David Safronetz et al.   PLoS Pathogens

A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease

(2010) C. B. Jonsson et al.   CLINICAL MICROBIOLOGY REVIEWS

Synthesis and anti-Hantaan virus activity of N1-3-fluorophenyl-inosine

(2009) Dong-Hoon Chung et al.   ANTIVIRAL RESEARCH

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

(2009) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Synthesis of 1-β-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus

(2008) Dong-Hoon Chung et al.   ANTIVIRAL RESEARCH

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

(2008) Janice M. Rusnak et al.   ANTIVIRAL RESEARCH

Treatment of hantavirus pulmonary syndrome

(2007) Colleen B. Jonsson et al.   ANTIVIRAL RESEARCH